← FDA Drug Approvals (Drugs@FDA)
BUPIVACAINE LIPOSOME
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2024-07-01
Drug application
- FDA Application #
ANDA214348- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPIVACAINE LIPOSOME
- Generic name
- BUPIVACAINE
- Active ingredients
- BUPIVACAINE
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- HENGRUI PHARMA
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- First approval
- 2024-07-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown